Evofem Biosciences' : Proxy for 14 September 2023 Annual Mee

the first and only FDA-approved, on demand, hormone-free contraceptive vaginal gel. Our expenses were reduced by 42% in a post-COVID environment, which enabled us to dramatically reduce our net loss,...

Related Keywords

High Bluff , California , United States , San Diego , Evofem Biosciences , Ivy Zhang , Saundra Pelletier , Evofem Biosciences Inc , Human Services , Hargreaves Savitch , Our Mission , Company Executive , Us Department Of Health , Annual Meeting , Proxy Statement , Daylight Time , Fellow Stockholders , Phexxi Access , Affordable Care Act , Prior Authorization , Co Pay Card , Third Consecutive Year , Revenue Growth , Restated Certificate , Authorized Shares , Chief Executive Officer , Bluff Drive , Preferred Shares , Executive Address , Markets ,